Clinical trials
Cardiovascular Diseases clinical trials
Below are recruiting cardiovascular diseases clinical trials, each written for real people, not researchers. We’re tracking 794 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06732102Recruiting
Philly Heart Health Study: DECIDE+
This study tests a program to help Philadelphians with conditions like high blood pressure, diabetes, or weight concerns and unmet social needs (like food or housing) get better health support. You'll work with a community health worker to learn ways to improve your health.
Philadelphia, PennsylvaniaAges 35–75 - NCT06742567RecruitingPhase 3
Apixaban to prevent blood clots after a heart attack
This trial tests whether the blood thinner apixaban can prevent dangerous blood clots from forming in the heart's main pumping chamber after a specific type of heart attack. It is for patients who have severe weakness of the left ventricle and no clot already present.
Karachi, SindhAges 18–75 - NCT06743568Recruiting
Comparing new valves for tight aortic valve in enlarged aorta
This trial tests two types of replacement heart valves (self-expanding and balloon-expanding) in people who have severe aortic stenosis (tight heart valve) and an enlarged aorta (the main blood vessel from the heart). The goal is to see which valve type works better for these patients.
Beijing, Beijing MunicipalityAges 65 years+ - NCT06746233Recruiting
Balloon versus stent for heart attack treatment
This trial compares a drug-coated balloon to a drug-coated stent for opening blocked arteries during a heart attack. It aims to see which device works better for patients having a specific type of heart attack called STEMI.
Banja LukaAges 18 years+ - NCT06747806Recruiting
A heart surgery biobank study
This study collects tissue samples from children and adults having heart surgery. The samples will help researchers learn more about heart conditions and improve future treatments.
Hyde Park, IllinoisAges Any age - NCT06768398Recruiting
AI study for heart and blood vessel health
This study uses artificial intelligence (AI) to analyze medical images of blood vessels. It aims to help patients with heart or blood vessel conditions, including smokers and those with high blood pressure, by improving how doctors spot problems early.
ShatinAges 19 years+ - NCT06768528Recruiting
Galectin-3 and atrial fibrillation after heart bypass
This trial checks if a protein called galectin-3 can help predict who will develop an irregular heartbeat (atrial fibrillation) after coronary artery bypass surgery. It aims to find ways to better monitor and treat heart patients after surgery.
São Paulo, São PauloAges 18 years+ - NCT06774586Recruiting
Study of blood vessel health in children
This study examines the health of blood vessels in children ages 6 to 17, using a non-invasive device called Vicorder to measure vessel stiffness. It aims to understand how blood vessel walls work in youth.
BolognaAges 6–17 - NCT06776159Recruiting
Standardizing blood thinner shots for heart patients
This study tests whether a standard way of giving blood thinner shots (LMWH) to people with heart disease in the cardiac care unit improves care. It is for Chinese patients who are awake and can make their own decisions.
Hong KongAges 18 years+ - NCT06784895Recruiting
Women-only cardiac rehab program
This trial tests a cardiac rehab program designed just for women. It aims to see if a women-only setting helps with recovery after heart problems or procedures.
Ann Arbor, MichiganAges 40–80 - NCT06791551Recruiting
Non-drug therapy before heart surgery to protect the brain
This study tests whether a simple, non-drug, non-surgical program before heart surgery can help protect your brain. It is for people with heart disease who are at higher risk for problems like stroke after surgery.
Beijing, Beijing MunicipalityAges 18–80 - NCT06793930Recruiting
A personalized program to improve health in metabolic syndrome
This study tests a personalized program that helps people with metabolic syndrome make healthy changes to their diet and activity. It is designed for Chinese adults who live at home and can use a digital device.
Hong KongAges 18 years+ - NCT06813911RecruitingPhase 3
Testing pelacarsen for high Lp(a) in heart disease patients
This trial tests a new medicine called pelacarsen for people with very high Lp(a) (a type of cholesterol) and existing heart or blood vessel disease. It aims to see if adding pelacarsen to your current cholesterol treatment can lower your Lp(a) levels further.
Birmingham, AlabamaAges 18–80 - NCT06826872RecruitingPhase 2
Testing SPC1001 for essential hypertension
This trial tests an oral medication called SPC1001 to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure not caused by another condition). It may help if you have mild to moderate high blood pressure.
SeoulAges 19–75 - NCT06828692Recruiting
Using computer tools to find the best blood pressure medicine for you
This trial tests a computer program that helps doctors choose the most suitable blood pressure medicine for each person. If you have high blood pressure and are taking none or two types of medication, this study may help find a better treatment plan.
Shenzhen, ShenzhenAges 35–79 - NCT06831890Recruiting
Smartphone heart risk check study
This study sees if a smartphone app can safely estimate your heart risk without a doctor visit. It's for people who don't have heart disease or diabetes and can use their own phone.
BernAges 40–69 - NCT06861062Recruiting
Vitamin D and yeast beta-glucan for type 2 diabetes
This trial tests if taking vitamin D3 and yeast beta-glucan supplements can help control blood sugar and lower heart disease risk in people with type 2 diabetes. It may be an option for those who want to see if supplements can improve their diabetes management.
Nanning, GuangxiAges 40–79 - NCT06870591Recruiting
Heart measurement device study
This trial tests a new device that measures heart function without needing an invasive catheter. It aims to see if the device works as well as the standard right heart catheterization procedure.
Huntsville, AlabamaAges 18 years+ - NCT06875973RecruitingPhase 3
Pelacarsen long-term extension study
This trial is for people who have already finished taking pelacarsen in a previous study. It offers continued access to the drug and checks long-term safety.
Birmingham, AlabamaAges 18–100 - NCT06886789Recruiting
Staying healthy after cardiac rehab
This study tests a program to help people who have finished cardiac rehab keep up their healthy habits. The program uses a smartphone app and check-in calls to support your progress.
Providence, Rhode IslandAges 18 years+ - NCT06908590Recruiting
Community health worker help for heart rehab after a heart event
This trial tests whether a community health worker (a trained person from your community) can help people with low income join and stick with a heart rehab program after a heart event. The goal is to make heart recovery easier and more accessible.
Baltimore, MarylandAges 21 years+ - NCT06908759Recruiting
Fall risk in older adults after heart rehab
This study looks at whether a special cardiac rehab program can help older adults who recently had a heart event improve their balance and reduce their risk of falling. It's designed for people age 65 and older who are now stable enough to begin rehab.
Rome, RMAges 65 years+ - NCT06909682Recruiting
AI monitoring with wearables for chronic heart failure
This trial tests an AI system that uses wearable devices and mini-invasive tools to monitor people with chronic heart failure. The goal is to detect changes early and help manage the condition at home.
SalernoAges 19 years+ - NCT06915220Recruiting
ADAPT heart rehab app study
This study tests if a smartphone app can help you stay active after finishing cardiac rehab. You might qualify if you own a smartphone and recently completed heart rehab at Michigan Medicine.
Ann Arbor, MichiganAges 18 years+
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiovascular diseases?
- Yes. Clin2 currently lists 794 recruiting cardiovascular diseases studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiovascular diseases trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiovascular diseases trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.